RecruitingNot ApplicableNCT03567213

Investigation on the Cortical Communication (CortiCom) System

Sponsor

Johns Hopkins University

Enrollment

3 participants

Start Date

Dec 14, 2021

Study Type

INTERVENTIONAL

Conditions

Amyotrophic Lateral Sclerosis locked-in Syndrome Brainstem Stroke tetraplegia

Summary

The CortiCom system consists of 510(k)-cleared components: platinum PMT subdural cortical electrode grids, a Blackrock Microsystems patient pedestal, and an external NeuroPort Neural Signal Processor. Up to two grids will be implanted in the brain, for a total channel count of up to 128 channels, for six months. In each participant, the grid(s) will be implanted over areas of cortex that encode speech and upper extremity movement.

Eligibility

Min Age: 22 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Surgical implantation of CortiCom system for people with amyotrophic lateral sclerosis, brainstem stroke, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 22 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESurgical implantation of CortiCom system

Implantation of Cortical communication system, consisting of one or two Electrocorticography (ECoG) grids connected to a transcutaneous patient pedestal.